Cargando…

Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients

BACKGROUND: Increasing evidence demonstrates that by acting as microRNA sponges modulating gene expression at the transcriptional or post-transcriptional level, circular RNAs (circRNAs) participate in the pathogenesis of a variety of diseases and are considered ideal biomarkers of human disease. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yu-Lan, Yin, Juan, Hu, Tong, Zhang, Li-Ping, Wu, Long-Yun, Pang, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848015/ https://www.ncbi.nlm.nih.gov/pubmed/31749597 http://dx.doi.org/10.3748/wjg.v25.i41.6273

Ejemplares similares

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery
por: Lee, Dong-won, et al.
Publicado: (2017)

Circulating miRNAs as biomarkers for severe acute pancreatitis associated with acute lung injury
por: Lu, Xiao-Guang, et al.
Publicado: (2017)

Fatigue in patients with inflammatory bowel disease in Eastern China
por: Gong, Shan-Shan, et al.
Publicado: (2021)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2022)

Comparative study between bowel ultrasound and magnetic resonance enterography among Egyptian inflammatory bowel disease patients
por: Kamel, Shimaa, et al.
Publicado: (2020)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Disease impact on the quality of life of children with inflammatory bowel disease
por: Chouliaras, Giorgos, et al.
Publicado: (2017)

Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort
por: Lee, Way Seah, et al.
Publicado: (2016)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2018)

Transitions of care across hospital settings in patients with inflammatory bowel disease
por: Warren, Leigh R, et al.
Publicado: (2019)

Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease
por: Brnic, Darko, et al.
Publicado: (2020)

Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
por: Michaux, Mielle, et al.
Publicado: (2023)

Updated bone mineral density status in Saudi patients with inflammatory bowel disease
por: Ewid, Mohammed, et al.
Publicado: (2020)

Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
por: Cassol, Ornella Sari, et al.
Publicado: (2022)

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil
por: Parra, Rogerio S, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
por: Crepaldi, Martina, et al.
Publicado: (2023)

Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines
por: Kojima, Yuichiro, et al.
Publicado: (2018)

Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey
por: Daher, Saleh, et al.
Publicado: (2019)

Impact of pediatric inflammatory bowel disease diagnosis on exercise and sports participation: Patient and parent perspectives
por: Marchioni Beery, Renée M, et al.
Publicado: (2019)

Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease
por: Gong, Shan-Shan, et al.
Publicado: (2019)

SARS-CoV-2 in inflammatory bowel disease population: Antibodies, disease and correlation with therapy
por: Conti, Clara Benedetta, et al.
Publicado: (2022)

Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease
por: Huguet, Jose María, et al.
Publicado: (2021)

Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
por: Takamune, Debora Mayumi, et al.
Publicado: (2022)

Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients
por: Zhang, Hu, et al.
Publicado: (2021)

Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease
por: Fu, Nancy, et al.
Publicado: (2017)

Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nurses
por: Strohl, Matthew, et al.
Publicado: (2017)

Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study
por: Misra, Ravi, et al.
Publicado: (2019)

Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up
por: Tulumović, Emir, et al.
Publicado: (2021)

Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
por: Fang, Xiu-Cai, et al.
Publicado: (2022)

Immunocompromised Children With Acute Respiratory Distress Syndrome Possess a Distinct Circulating Inflammatory Profile
por: Nguyen, John, et al.
Publicado: (2023)

Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease
por: Rodriguez, Alexis, et al.
Publicado: (2017)

Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients
por: Zhong, Min, et al.
Publicado: (2020)

Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
por: Zaltman, Cyrla, et al.
Publicado: (2021)

Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort
por: Rifkin, Andrew S, et al.
Publicado: (2023)

Nailfold Capillaroscopy as a Biomarker in the Evaluation of Pediatric Inflammatory Bowel Disease
por: Kurowski, Jacob A, et al.
Publicado: (2021)

Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk
por: Papadavid, Evangelia, et al.
Publicado: (2016)

Current practice and clinicians’ perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians
por: Soobraty, Anisah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3i5e9l2qpb5d8ihpgpfotkdud3